Efficient genome editing in the non-human primate brain using programmable extracellular vesicles

Background and study focus

The available source is a bioRxiv preprint titled “Efficient genome editing in the non-human primate brain using programmable extracellular vesicles.” The title identifies the primary topics as genome editing, delivery to the non-human primate brain, and use of programmable extracellular vesicles as the delivery platform. The title suggests the manuscript addresses a delivery approach for genetic modification in primate neural tissue, but the full text of the manuscript was not included in the excerpt supplied for this rewrite.

Author list and institutional affiliations

The preprint lists a large multi‑author team. The first authors named include Xiuming Liang and Houze Zhou; other contributors include Zubair Ahmed Nizamudeen, Eleni Kyriakopoulou, Angharad E. Evans, Samantha Roudi and many more. Affiliated institutions explicitly reported in the source excerpt include Karolinska Institutet (Division of Biomolecular and Cellular Medicine, Department of Laboratory Medicine), Evox Therapeutics Ltd, and Xiamen University (State Key Laboratory of Cellular Stress Biology). The source provides a detailed author list and institutional affiliations for many contributors.

Preprint status and bibliographic details

This manuscript is posted on bioRxiv and is accompanied by the DOI https://doi.org/10.64898/2026.08.05.741964. The source includes the standard bioRxiv notice that the article is a preprint and has not been certified by peer review. The presence of the DOI and bioRxiv posting indicate the manuscript is publicly accessible in preprint form, but it remains unreviewed at the time of posting.

What the title reports: key topic areas

From the title alone, the report concerns three interrelated areas:

• Delivery modality: the use of programmable extracellular vesicles as a means to transport genome editing payloads.
• Target system: application in the non-human primate brain, implying in vivo primate neural delivery rather than cell lines or rodent models.
• Objective: achieving efficient genome editing, suggesting the authors aimed to demonstrate measurable editing activity in primate neural tissue.

These topic areas are taken directly from the title; specific experimental targets, payloads (for example CRISPR nucleases, base editors, or other editing systems), or measures of efficiency are not reported in the provided excerpt.

Details not present in the provided source excerpt

The excerpt supplied contains bibliographic and author information but does not include the manuscript text or results. The following critical details were not reported in the provided source and therefore cannot be summarized here:

• Experimental design and methods (delivery route, dosing, vesicle engineering, genome editing platform).
• Target genes or loci edited, and rationale for target selection.
• Quantitative editing efficiency and metrics used to assess editing.
• Safety and tolerability information, including histology, behavioural observations, or biochemical markers.
• Off‑target analyses and genomic integrity assessments.
• Animal numbers, primate species or strains used, and ethical approvals or oversight details.
• Any conclusions or authors’ interpretation of findings.

Because these items were absent from the excerpt, readers should not infer outcomes or claims beyond what appears in the title and accompanying metadata.

Implications, limitations, and recommended next steps for readers

Implications

• The title indicates a potentially important advance in in vivo delivery for neural genome editing if validated by data. The combination of extracellular vesicle platforms and primate brain application could be relevant for translational neuroscience and therapeutic development, subject to confirmation in the full manuscript and peer review.

Limitations

• The manuscript is a preprint and has not undergone peer review according to the source. The excerpt provided here lacks methods and results, so efficacy and safety cannot be assessed from the available text.

Recommended next steps for readers

• Consult the full bioRxiv preprint using the DOI provided to review experimental methods, results, figures, and the authors’ discussion.
• Await peer review and subsequent publication for validated and scrutinized data, or contact the corresponding author(s) listed in the full preprint for clarifications if required for research planning.

How to access the full preprint

The manuscript is posted on bioRxiv and can be accessed via the DOI: https://doi.org/10.64898/2026.08.05.741964. The bioRxiv listing includes the full author list and affiliations; the full text, figures, and supplementary materials (if posted) should be consulted there for complete details.

Note: This rewrite is based solely on the bibliographic and title information present in the supplied source excerpt. The excerpt did not contain the study’s methods, data, or conclusions; those were not reported and therefore are not summarized here.